Verano Health

Verano Health launched with a deliberately stripped-down SMS-based platform rather than building a full-featured mobile app. Their MVP consisted of two-way text messaging, weekly asynchronous coaching interactions, and basic health tracking—intentionally omitting video visits, complex dashboards, and integration with electronic health records. They shipped this core experience within months, validating demand with early Medicaid patients who had minimal smartphone literacy but consistent phone access. This constraint-driven approach proved prescient. Early signals showed 60%+ engagement rates on SMS interactions, far exceeding industry benchmarks for digital health. By avoiding expensive infrastructure, Verano could rapidly iterate based on actual patient behavior rather than assumed needs. However, the simplicity also limited clinical data collection initially, forcing them to build analytics capabilities later. Their execution prioritized accessibility over comprehensiveness—a bet that paid off when scaling across multiple state Medicaid programs, proving that underserved populations valued ease-of-use over feature density.

Verano Health built a telehealth platform targeting Medicaid patients with diabetes, focusing on SMS-based coaching rather than traditional app distribution. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Their go-to-market strategy centered on direct partnerships with health plans and Medicaid managed care organizations, recognizing that reaching 80 million Medicaid beneficiaries required institutional channels rather than consumer acquisition. This B2B2C approach positioned them to scale through existing healthcare infrastructure rather than competing for individual downloads. Early validation came through demonstrated clinical outcomes from their Healthy at Home program—weekly SMS coaching interactions showed measurable engagement among a population typically underserved by digital health. The fact that less than 1% of diabetic Medicaid patients received formal training created obvious demand. However, available sources don't specify which health plans adopted their platform, whether they faced payer reimbursement barriers, or how quickly partnerships materialized. Their distribution strategy appears sound in theory—leveraging Medicaid's institutional structure—but concrete evidence of market traction remains unclear from provided information.